These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26494636)

  • 1. Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's disease.
    Zorzi F; Calabrese E; Monteleone G
    Clin Sci (Lond); 2015 Dec; 129(12):1107-13. PubMed ID: 26494636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights on fibrosis in Crohn's disease.
    Bailey JR; Whiting CV; Tarlton JF; Bland PW; Probert CS
    Expert Rev Gastroenterol Hepatol; 2013 Aug; 7(6):497-9. PubMed ID: 23984996
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of initiation and progression of intestinal fibrosis in IBD.
    Latella G; Di Gregorio J; Flati V; Rieder F; Lawrance IC
    Scand J Gastroenterol; 2015 Jan; 50(1):53-65. PubMed ID: 25523556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant contribution of TRPC6 channel-mediated Ca
    Kurahara LH; Hiraishi K; Sumiyoshi M; Doi M; Hu Y; Aoyagi K; Jian Y; Inoue R
    J Smooth Muscle Res; 2016; 52(0):78-92. PubMed ID: 27818466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we prevent, reduce or reverse intestinal fibrosis in IBD?
    Latella G; Sferra R; Speca S; Vetuschi A; Gaudio E
    Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1283-304. PubMed ID: 23740440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of morphology for the comprehension of mechanisms of fibrosis in inflammatory enterocolitis.
    Geboes KP; Cabooter L; Geboes K
    Acta Gastroenterol Belg; 2000; 63(4):371-6. PubMed ID: 11233520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased gelsolin expression and retarded collagen lattice contraction with smooth muscle cells from Crohn's diseased intestine.
    Ehrlich HP; Allison GM; Page MJ; Kolton WA; Graham M
    J Cell Physiol; 2000 Feb; 182(2):303-9. PubMed ID: 10623895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intestinal flora and Crohn's disease].
    Desreumaux P; Colombel JF
    Ann Pharm Fr; 2003 Jul; 61(4):276-81. PubMed ID: 12843962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating fibrocytes and Crohn's disease.
    Sahebally SM; Burke JP; Chang KH; Kiernan MG; O'Connell PR; Coffey JC
    Br J Surg; 2013 Nov; 100(12):1549-56. PubMed ID: 24264775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we influence fibrosis in Crohn's disease?
    Assche GV
    Acta Gastroenterol Belg; 2001; 64(2):193-6. PubMed ID: 11475134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis.
    Vallance BA; Gunawan MI; Hewlett B; Bercik P; Van Kampen C; Galeazzi F; Sime PJ; Gauldie J; Collins SM
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G116-28. PubMed ID: 15778431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD.
    Latella G; Rogler G; Bamias G; Breynaert C; Florholmen J; Pellino G; Reif S; Speca S; Lawrance IC
    J Crohns Colitis; 2014 Oct; 8(10):1147-65. PubMed ID: 24731838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strictures in Crohn's Disease: From Pathophysiology to Treatment.
    Crespi M; Dulbecco P; De Ceglie A; Conio M
    Dig Dis Sci; 2020 Jul; 65(7):1904-1916. PubMed ID: 32279173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrostenosing Crohn's Disease: Pathogenetic Mechanisms and New Therapeutic Horizons.
    Mignini I; Blasi V; Termite F; Esposto G; Borriello R; Laterza L; Scaldaferri F; Ainora ME; Gasbarrini A; Zocco MA
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease.
    Stallmach A; Schuppan D; Riese HH; Matthes H; Riecken EO
    Gastroenterology; 1992 Jun; 102(6):1920-9. PubMed ID: 1587410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of myofibroblasts during the development of fibrosis in Crohn's disease.
    Li C; Kuemmerle JF
    J Dig Dis; 2020 Jun; 21(6):326-331. PubMed ID: 32092217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The connective tissue changes of Crohn's disease.
    Shelley-Fraser G; Borley NR; Warren BF; Shepherd NA
    Histopathology; 2012 Jun; 60(7):1034-44. PubMed ID: 22008086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of interleukin-17A-induced expression of heat shock protein 47 in intestinal fibrosis in Crohn's disease.
    Honzawa Y; Nakase H; Shiokawa M; Yoshino T; Imaeda H; Matsuura M; Kodama Y; Ikeuchi H; Andoh A; Sakai Y; Nagata K; Chiba T
    Gut; 2014 Dec; 63(12):1902-12. PubMed ID: 24534724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-fibrotic Drugs for Crohn's Disease: Ready for Prime Time?
    Argollo M; Gilardi D; Roda G; Fiorino G; Peyrin-Biroulet L; Danese S
    Curr Pharm Des; 2019; 25(1):47-56. PubMed ID: 30848192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.